Я нашел самый быстрый способ поднять свой независимый и бесплатный VPN
Сразу оговорка, платить придётся только за хостинг.
1️⃣ Покупаем сервер где-то на просторах интернета. Конечно же сервер должен находиться за пределами страны. Например я закупился на https://eurohoster.org/ (не реклама). Проверяйте лимиты по трафику, в идеале - без ограничений.
2️⃣ Ставим docker
sudo apt install docker.io
Если удобней с DockerCompose то ставим и его
sudo apt install docker-compose
3️⃣ Ставим WG-EASY
Самый простой способ поднять сервис WireGuard c WebUI это проект wg-easy
Код и документация здесь
https://github.com/weejewel/wg-easy
Запускаем контейнер:
https://github.com/weejewel/wg-easy#2-run-wireguard-easy
Для тех кто с DockerCompose, забираем файл здесь:
https://gist.github.com/paulwinex/be87f79687b96786098ec8fa6a8e251c
В обоих случаях потребуется поменять две переменные:
WG_HOST - внешний статичный IP вашего сервера
PASSWORD - придумайте пароль для WEB UI
Остальные параметры указаны ниже на странице github https://github.com/weejewel/wg-easy#options
4️⃣ Ставим клиента
Все доступные клиенты здесь
https://www.wireguard.com/install/
Есть возможность добавить клиента в Network Manager для управления подключением через UI. Установка зависит от вашей системы, ищите мануалы в сети, их много.
https://github.com/max-moser/network-manager-wireguard
Скрипт установки для RasperryPi
https://gist.github.com/paulwinex/c2c4090f19dbe8bd1253c5744f3f06e1
ЗЫ. Конечно же это не "самый простой" и далеко не единственный способ. А просто тот, который использую я сам.
#offtop#linux
🚨 Just had an intriguing discovery at the Blokhin Institute in Moscow, Russia.
While waiting for my doctor's appointment, I decided to explore the institute's museum. Among the exhibits, I stumbled upon a personal letter and invitation from Edward Kennedy to one of the institute's doctors. This was during the Cold War era, which makes this find even more fascinating.
It seems that even amidst political tensions, there was recognition of the significant contributions Russia has made to arts and sciences. This glimpse into history reminds us of the importance of collaboration in fields like medicine, where advancements benefit everyone, regardless of borders.
#BlokhinInstitute#ColdWarHistory#MedicalResearch#InternationalCollaboration#RussianAchievements
Tessera Therapeutics Secures $50M
Tessera Therapeutics has raised $50 million in funding on December 18, 2024. The early-stage life sciences company is at the forefront of Gene Writing™, a cutting-edge biotechnology aimed at transforming medicine and scientific research. More details available on their official website: Tessera Therapeutics
#TesseraTherapeutics#Funding#LifeSciences#Biotechnology#GeneWriting#Healthcare#MedicalResearch
$140M Funding for Ottimo Pharma
Ottimo Pharma announces a funding round of $140 million set for December 19, 2024. The company focuses on developing bi-functional medicines aimed at improving the lives of individuals living with cancer.
Learn more
#Funding#OttimoPharma#Cancer#BiFunctionalMedicines#Healthcare#Pharmaceuticals#LifeSciences#Investments#MedicalResearch#Oncology#HealthTech#Biotechnology
PeproMene Bio Secures $11M Round
PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders.
More info: PeproMene Bio
#Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment
$60M Funding for Psioxus
Psioxus Therapeutics has successfully secured $60M in funding as part of its latest round, scheduled for December 17, 2024. This funding aims to advance its innovative tumor gene therapy platform focused on improving cancer treatment outcomes.
#Funding#Cancer#Biotech#Oncology#GeneTherapy#Therapeutics#ClinicalStage#Investment#Healthcare#Psioxus#AkamisBio#Tumor#LifeScience#MedicalResearch#Therapy#Innovative#Impact#Technology#Platform